Status:
COMPLETED
A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects
Lead Sponsor:
Galapagos NV
Conditions:
Healthy
Eligibility:
MALE
40-60 years
Phase:
PHASE1
Brief Summary
This will be a drug-drug interaction study to evaluate the effect of multiple oral doses of GLPG0634 on the single dose pharmacokinetic profile of midazolam administered in fasted normal healthy males...
Eligibility Criteria
Inclusion
- male, between 40 and 60 years of age, inclusive
- within BMI range 18 to 30 kg/m2, inclusive
Exclusion
- Any condition that might interfere with the procedures or tests in this study
- Drug or alcohol abuse
- Smoking
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01798979
Start Date
February 1 2013
End Date
April 1 2013
Last Update
May 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Covance Clinical Research Unit
Madison, Wisconsin, United States, 53704